Trial reportBMC anesthesiology2026
Comparison of propofol and propofol-ketamine anesthesia on optic nerve sheath diameter in endovascular cerebral aneurysm procedures: a prospective randomized study.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07542015 (Comparison of Propofol and Propofol-Ketamine Anesthesia on Optic Nerve Sheath Diameter in Endovascular Cerebral Aneurysm Procedures), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of Propofol and Propofol-Ketamine Anesthesia on Optic Nerve Sheath Diameter in Endovascular Cerebral Aneurysm Procedures
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular treatment of unruptured intracranial aneurysms requires anesthetic strategies that maintain cerebral perfusion and hemodynamic stability while avoiding increases in intracranial pressure (ICP). Optic nerve sheath diameter (ONSD) measured by ultrasonography is commonly used as a noninvasive surrogate marker of ICP. This study compared propofol and propofol-ketamine anesthesia with respect to perioperative ONSD, cerebral oxygenation, and hemodynamic parameters during endovascular aneurysm procedures.
methodsIn this prospective, randomized, single-center, observer-blinded trial, 40 adults undergoing elective endovascular treatment of unruptured intracranial aneurysms were allocated to a propofol group (P, n = 20) or a propofol-ketamine group (KP, n = 20). Standardized anesthetic protocols and ventilation targeting normocapnia were used in both groups. ONSD, regional cerebral oxygen saturation (rSO₂), bispectral index (BIS), and hemodynamic variables were recorded at predefined perioperative time points. The primary outcome was the temporal change in mean ONSD. Mean ONSD was analyzed using a linear mixed-effects model including group, time, and group × time interaction. Secondary longitudinal outcomes were analyzed using exploratory mixed-effects models.
resultsBaseline demographic and clinical characteristics were comparable between groups. Total propofol consumption was significantly lower in the KP group, whereas remifentanil use showed a non-significant trend toward reduction. In the primary mixed-effects analysis, the group × time interaction for mean ONSD was not statistically significant, indicating that the temporal trajectory of ONSD did not differ between groups. The main effect of group was also not significant, whereas the main effect of time was significant. Exploratory analyses of secondary longitudinal outcomes showed significant group × time interactions for selected hemodynamic, ventilation-related, anesthetic depth, and cerebral oxygenation parameters, including DBP, MAP, EtCO₂, BIS, and mean rSO₂. Heart rate and SpO₂ trajectories were comparable between groups.
conclusionsIn this small randomized cohort of patients undergoing elective endovascular treatment of unruptured intracranial aneurysms, propofol and propofol-ketamine anesthesia showed comparable ONSD trajectories over time. The propofol-ketamine regimen was associated with reduced propofol consumption and exploratory evidence of differential perioperative hemodynamic and cerebral oxygenation profiles. However, the study was not powered to evaluate safety outcomes or rare adverse events. Larger neurosurgical trials are required before firm conclusions regarding safety and clinical feasibility can be drawn.
trial registrationThe study was registered at ClinicalTrials.gov (identifier NCT07542015) on April 14, 2026. Retrospectively registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.